Post-hoc analysis showed that, compared to the control group, the tinnitus group had significantly increased the IL-1β mRNA levels in the cochlea (3.5±1.1 versus 2.8±0.3, p = 0.031) and IC (2.9±0.5 versus 1.2±0.5, p<0.001). The gene discussed is IL1B; the disease is Tinnitus.